Skip to content
HowShorted

Quince Therapeutics, Inc. short interest in 2024

In 2024, Quince Therapeutics, Inc.'s disclosed short interest ran from 4.78% of shares outstanding on 12 Jan 2024 to 5.45% on 31 Dec 2024, a change of +0.67 percentage points. The year's high was 5.46% on 28 Jun 2024 and its low 4.07% on 15 Nov 2024, averaging 4.71% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 59.77 days on 15 Oct 2024. Full history: Quince Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Quince Therapeutics, Inc. in 2024

2024 in figures

Start of year
4.78% (12 Jan 2024)
End of year
5.45% (31 Dec 2024)
Change
+0.67 pp
High
5.46% (28 Jun 2024)
Low
4.07% (15 Nov 2024)
Average
4.71%
Highest days to cover
59.77 (15 Oct 2024)
SEC filings marked
6

Every report in 2024

Quince Therapeutics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20244.78%19.88
31 Jan 20244.44%21.48
15 Feb 20244.42%31.27
29 Feb 20244.43%25.29
15 Mar 20244.35%43.19
28 Mar 20244.30%49.76
15 Apr 20244.30%22.4610-K filed
30 Apr 20244.56%18.31
15 May 20244.60%18.7410-Q filed
31 May 20244.73%18.26
14 Jun 20245.38%14.81
28 Jun 20245.46%29.85
15 Jul 20244.81%29.02
31 Jul 20244.55%53.08
15 Aug 20244.45%4.1010-Q filed, results (8-K)
30 Aug 20244.80%10.20
13 Sep 20244.54%25.33
30 Sep 20244.44%20.36
15 Oct 20244.42%59.77
31 Oct 20245.42%1.16
15 Nov 20244.07%4.2810-Q filed, results (8-K)
29 Nov 20244.94%7.06
13 Dec 20245.44%9.49
31 Dec 20245.45%13.84

See also: Quince Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.